Our mission is to make molecular cancer diagnostic accurate, affordable and available to all.
One test for the early diagnosis of esophageal, stomach, pancreatic, liver, colorectal, kidney and bladder cancer.
There are more than one hundred types of cancer, but only four have preventive screening tests available. Unfortunately, for the majority of cancers, early diagnosis is difficult to achieve and very often made by random chance.
Even though science has identified different biomarkers common among multiple cancers, it is very challenging to create accurate screening tests due to the diversity of the biomarkers. The three most important biomarker classes are DNA, microRNA, proteins, and so far each required a different detection method.